What is he best known for?
The fields of study he is best known for:
- Gene
- Internal medicine
- Enzyme
Peter Riederer mostly deals with Internal medicine, Endocrinology, Parkinson's disease, Neuroscience and Substantia nigra.
His studies link Phosphorylation with Internal medicine.
His biological study deals with issues like Human brain, which deal with fields such as Receptor.
His Parkinson's disease research is multidisciplinary, incorporating elements of Dopaminergic and Central nervous system disease, Degenerative disease.
He interconnects Alzheimer's disease, Disease and NMDA receptor in the investigation of issues within Neuroscience.
His Substantia nigra study combines topics in areas such as Oxidative stress and Ferritin.
His most cited work include:
- Allelic Variation of Human Serotonin Transporter Gene Expression (1944 citations)
- Iron, brain ageing and neurodegenerative disorders (1305 citations)
- Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains. (1202 citations)
What are the main themes of his work throughout his whole career to date?
The scientist’s investigation covers issues in Internal medicine, Endocrinology, Parkinson's disease, Neuroscience and Pharmacology.
Endocrinology is frequently linked to Human brain in his study.
His Parkinson's disease study integrates concerns from other disciplines, such as Bioinformatics and Degenerative disease.
His Neuroscience research includes themes of Glutamate receptor, Psychosis and Neurodegeneration.
He has included themes like NMDA receptor, Selegiline, Monoamine oxidase B, Monoamine oxidase and Rasagiline in his Pharmacology study.
His Disease research incorporates elements of Neurology and Immunology.
He most often published in these fields:
- Internal medicine (31.84%)
- Endocrinology (28.23%)
- Parkinson's disease (21.86%)
What were the highlights of his more recent work (between 2009-2021)?
- Parkinson's disease (21.86%)
- Disease (13.77%)
- Internal medicine (31.84%)
In recent papers he was focusing on the following fields of study:
Parkinson's disease, Disease, Internal medicine, Neuroscience and Neurology are his primary areas of study.
His study in Parkinson's disease is interdisciplinary in nature, drawing from both Dopamine and Pharmacology.
In his study, Neurotrophic factors is strongly linked to Neuroprotection, which falls under the umbrella field of Dopamine.
His Disease research is multidisciplinary, incorporating perspectives in Rat model and Bioinformatics.
The Internal medicine study combines topics in areas such as Gastroenterology, Endocrinology and Oncology.
His studies in Neuroscience integrate themes in fields like Neurodegeneration and Parkinsonism.
Between 2009 and 2021, his most popular works were:
- PGC-1α, A Potential Therapeutic Target for Early Intervention in Parkinson’s Disease (569 citations)
- Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions (361 citations)
- The relevance of iron in the pathogenesis of Parkinson's disease. (224 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Internal medicine
- Enzyme
His primary areas of study are Parkinson's disease, Disease, Neurology, Internal medicine and Neuroscience.
His work carried out in the field of Parkinson's disease brings together such families of science as Dopamine and Pharmacology.
His work on Alzheimer's disease as part of general Disease research is often related to Clinical neurology, thus linking different fields of science.
Internal medicine is closely attributed to Endocrinology in his work.
He is interested in Oxidative stress, which is a branch of Endocrinology.
His work investigates the relationship between Neuroscience and topics such as Neurodegeneration that intersect with problems in Memory impairment.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
